BioSpace News Archive

Bio-Techne Corporation has partnered with Autolomous to implement a first of its kind electronic batch record system, AutoloMATETM, at Bio-Techne’s GMP cellular manufacturing center.

CASI Pharmaceuticals, Inc. announced First-Patient-In in the Phase 1 dose escalation and expansion study of CID-103, an investigational novel anti-CD38 monoclonal antibody, in patients with previously treated, relapsed or refractory multiple myeloma.

MYND Life Sciences Inc. a drug research and development company focused on novel psychedelic drug development, diagnostic approaches and pharmaceuticals, is pleased to announce it has filed additional provisional patents that utilize various psilocybin analogs to target clinical depression.

Seres Therapeutics, Inc. today announced that Terri Young, Ph.D., R.Ph., Chief Commercial and Strategy Officer of Seres Therapeutics, will present at the JMP Securities Life Sciences Conference on Thursday, June 17, 2021 at 1:00 p.m. ET.

AVROBIO, Inc. today announced Geoff MacKay, president and CEO of AVROBIO, will present at the JMP Securities Life Sciences Conference at 10:30 a.m. ET on Thursday, June 17, 2021.

Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced it has completed its previously announced acquisition of Ritter GmbH and its affiliates.

Rising prevalence of infectious diseases including SARS-CoV-2 infection and technological advancements in diseases diagnostics to spur market growth.

NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced that it will participate in a fireside chat at the JMP Securities Life Sciences Conference

Increasing significance of contract research organizations in drug discovery initiatives is driving revenue growth of the market.

Increasing importance of stem cells in regenerative medicine and tissue engineering, growing network of stem cell banks, and rising awareness regarding benefits of stem cell preservation are key factors driving market growth.